Metabolic reprogramming in lung cancer and its clinical implication

23Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Lung cancer has posed a significant challenge to global health, and related study has been a hot topic in oncology. This article focuses on metabolic reprogramming of lung cancer cells, a process to adapt to energy demands and biosynthetic needs, supporting the proliferation and development of tumor cells. In this study, the latest studies on lung cancer tumor metabolism were reviewed, including the impact of metabolic products and metabolic enzymes on the occurrence and development of lung cancer, as well as the progress in the field of lung cancer treatment targeting relevant metabolic pathways. This provides some promising potential directions into exploring lung cancer tumor metabolism and helps researchers to better understand lung cancer.

Cite

CITATION STYLE

APA

Huang, Q., Fan, L., Gong, M., Ren, J., Chen, C., & Xie, S. (2024). Metabolic reprogramming in lung cancer and its clinical implication. Frontiers in Pharmacology. Frontiers Media SA. https://doi.org/10.3389/fphar.2024.1516650

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free